CJ BIOSCIENCE
LIVE

Serial Number

97122539

Owner

CJ Corporation

Attorney

Boris Umansky

Filing Date

Nov 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CJ BIOSCIENCE Trademark

Serial Number: 97122539 • Registration: 7394693

CJ BIOSCIENCE is a trademark filed by CJ Corporation on November 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

CJ Corporation (127 trademarks)

Seoul 04637 , KR

Entity Type: 03

Trademark Details

Filing Date

November 12, 2021

Registration Date

May 28, 2024

Published for Opposition

March 12, 2024

Goods & Services

preserved, frozen, dried and cooked fruits and vegetables; processed vegetables and fruits; preserved, dried and cooked fruit and vegetables; powdered milk; dairy-based beverages; cream, being dairy products; dairy-based spreads; lactic acid bacteria drinks; milk products excluding ice cream, ice milk and frozen yogurt

food for babies; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vitamin preparations; reagents for use in veterinary genetic testing; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biological preparations for the treatment of cancer; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; dietetic foods adapted for medical purposes; reagents for use in medical genetic testing; genetic identity tests comprised of reagents for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; probiotic bacterial formulations for medical use; probiotic preparations for medical use; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating sunburn; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for skin care; pharmaceutical preparations, namely, appetite suppressant; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceuticals, namely, anti-infectives; pharmaceutical preparations for wounds; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating allergies; medicines for adjusting the menstrual cycle; medicines for intestinal disorders; medicines for the treatment of gastrointestinal diseases; probiotic supplements; pharmaceutical preparations for animal skincare; mineral food supplements; nutraceuticals for use as a dietary supplement; nutraceutical preparations mainly based on lactic acid bacteria for use as a dietary supplement; nutraceutical preparations mainly based on probiotics for use as a dietary supplement; cultures of microorganisms for medical or veterinary use; bacterial preparations for medical and veterinary use; health supplements food mainly based on processed fruits; health supplements food mainly based on processed vegetable; health supplements food mainly based on processed meats; health supplements food mainly based on bifidus bacteria; health supplements food mainly based on lactic acid bacteria; health supplements food mainly based on probiotics extracted from dairy products; health supplements food mainly based on probiotics of lactic acid bacteria; health supplements food mainly based on processed seeds; health supplements food mainly based on processed fish and shellfish; health supplements food mainly based on probiotics of lactic acid bacteria extracted from dairy products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 28, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 28, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 22, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 27, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 27, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 27, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2023 CRFA
ASSIGNED TO LIE
Sep 26, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 8, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 6, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 6, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 6, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 3, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 3, 2022 GNSL
SUSPENSION LETTER WRITTEN
Aug 3, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 19, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 12, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 19, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2021 NWOS
NEW APPLICATION ENTERED
Nov 16, 2021 NWAP